Epilepsy Drugs Market Report and Global Forecast 2024-2030, Featuring Eisai, UCB, H. Lundbeck, GW Pharmaceuticals, Abbott, Alkem Laboratories, Bausch Health Companies, GSK, Novartis and Pfizer
May 06, 2024 04:04 ET
|
Research and Markets
Dublin, May 06, 2024 (GLOBE NEWSWIRE) -- The "Epilepsy Drugs Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Top Companies Analysis" report has...
Migraine in America: Key Insights into Treatment Awareness & Satisfaction - Exploring HCP Engagement and Migraine Treatment Experiences Among Patients
April 02, 2024 07:18 ET
|
Research and Markets
Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "Migraine in America 2023: Key Insights into Treatment Awareness & Satisfaction" report has been added to ResearchAndMarkets.com's offering. In...
Antiepileptic Drugs Market Size to Surpass USD 22.37 billion by 2030, exhibiting a CAGR of 4.4%
November 20, 2023 06:16 ET
|
Fortune Business Insights
Pune, India, Nov. 20, 2023 (GLOBE NEWSWIRE) -- The antiepileptic drugs market size is anticipated to surge from USD 16.50 billion in 2023 to USD 22.37 billion by 2030, exhibiting a CAGR of 4.4% over...
Second Generation Anti-Epileptic Drugs (AEDs) Dominate the Market in 2022, While Third Generation AEDs Projected to Exhibit the Fastest Growth
November 06, 2023 06:58 ET
|
Research and Markets
Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Anti-Epileptic Drugs Market: Analysis By Drug Generation, By Distribution Channel, By Region Size and Trends with Impact of COVID-19 and...
Proven Track Record in Epilepsy Treatment Propels Global Phenobarbital Market; Anticipated to Reach $2.23 Billion by 2030
September 08, 2023 08:28 ET
|
Research and Markets
Dublin, Sept. 08, 2023 (GLOBE NEWSWIRE) -- The "Phenobarbital Market, By Indication, By Dosage Form, By Distribution Channel, and By Geography- Size, Share, Outlook, and Opportunity Analysis, 2023 -...
NeuroSigma Receives FDA Breakthrough Device Designation for Monarch eTNS System®
February 22, 2022 11:00 ET
|
NeuroSigma, Inc.
LOS ANGELES, Feb. 22, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a bioelectronic medical device company, today announced FDA Breakthrough Device Designation for its Monarch eTNS System® for...
Global Epilepsy Drugs Market (2020 to 2027) - Featuring UCB, Eisai, H. Lundbeck and GW Pharmaceuticals
September 15, 2021 04:28 ET
|
Research and Markets
Dublin, Sept. 15, 2021 (GLOBE NEWSWIRE) -- The "Epilepsy Drugs Market, Global Forecast, Impact of COVID-19, Industry Trends, by Drugs Category, Growth, Opportunity Company Analysis" report has been...
Antiepileptic Drugs Market to Reach USD 20.33 Billion by 2026; Rising Production of Innovative Drugs to Boost Growth: says Fortune Business Insights™
April 08, 2020 12:20 ET
|
Fortune Business Insights
Pune, April 08, 2020 (GLOBE NEWSWIRE) -- The global antiepileptic drugs (AED) market is set to gain traction from the ever-increasing initiatives by manufacturers for producing novel and generic...